AGILENT TECHNOLOGIES, INC.
Key Highlights
- Financial reporting covers revenue, costs, and expenses for fiscal years 2023-2025.
- Performance is analyzed across Americas, Europe, Asia Pacific regions and Pharmaceutical, Chemical, Diagnostics, Food, Academia, Environmental market segments.
- Product performance is categorized into Instrumentation and Non-Instrumentation.
- Notable events include BIOVECTRA on September 20, 2024, and a subsequent event in November 2025.
Financial Analysis
AGILENT TECHNOLOGIES, INC. Annual Report - How They Did This Year
The report includes references to product and service revenue, cost of sales, research and development expenses, and selling, general, and administrative expenses for fiscal years 2025, 2024, and 2023.
Financial breakdowns are noted by geographic regions, including Americas, Europe, and Asia Pacific. Market segments referenced include Pharmaceutical, Chemical, Diagnostics, Food, Academia, and Environmental. The report also categorizes performance by product type, distinguishing between Instrumentation and Non-Instrumentation.
A mention of "BIOVECTRA" is noted on September 20, 2024.
A subsequent event is referenced in November 2025.
Key Takeaways:
- The company's financial reporting structure covers revenue, costs, and expenses across fiscal years 2023-2025.
- Performance is analyzed across key geographic regions and market segments.
- Product types are differentiated between Instrumentation and Non-Instrumentation.
- Notable events include a mention of "BIOVECTRA" in September 2024 and a subsequent event in November 2025.
Document Information
SEC Filing
View Original DocumentAnalysis Processed
December 23, 2025 at 08:53 AM
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.